Over the upcoming years, the revenue of the Turkish pharmaceuticals market is forecast to increase in all segments. Concerning the selected segments, vaccines had the largest revenue in 2022 with 483 million U.S. dollars. It was followed by oncology drugs, recording 258.3 million U.S. dollars of revenue in the same year.
Data provided by Statista Market Insights are estimates.
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.
The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G).
Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi
A detailed methodology can be found in the Statista Market Outlook.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (June 1, 2023). Revenue of the pharmaceuticals market in Turkey from 2018 to 2027, by segment (in million U.S. dollars) [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1409387/turkey-pharmaceuticals-market-revenue-by-segment
Statista. "Revenue of the pharmaceuticals market in Turkey from 2018 to 2027, by segment (in million U.S. dollars)." Chart. June 1, 2023. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1409387/turkey-pharmaceuticals-market-revenue-by-segment
Statista. (2023). Revenue of the pharmaceuticals market in Turkey from 2018 to 2027, by segment (in million U.S. dollars). Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1409387/turkey-pharmaceuticals-market-revenue-by-segment
Statista. "Revenue of The Pharmaceuticals Market in Turkey from 2018 to 2027, by Segment (in Million U.S. Dollars)." Statista, Statista Inc., 1 Jun 2023, https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1409387/turkey-pharmaceuticals-market-revenue-by-segment
Statista, Revenue of the pharmaceuticals market in Turkey from 2018 to 2027, by segment (in million U.S. dollars) Statista, https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1409387/turkey-pharmaceuticals-market-revenue-by-segment (last visited November 10, 2024)
Revenue of the pharmaceuticals market in Turkey from 2018 to 2027, by segment (in million U.S. dollars) [Graph], Statista, June 1, 2023. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1409387/turkey-pharmaceuticals-market-revenue-by-segment